Faculty profile
Donald Miller
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma
Neuro-Oncology · 2025
Pharmacokinetics of a once-daily tacrolimus formulation in first nations and caucasian liver transplant recipients.
Transplant international : official journal of the European Society for Organ Transplantation · 2021
Evaluation of percutaneous permeation of repellent DEET and sunscreen oxybenzone from emulsion-based formulations in artificial membrane and human skin.
Acta pharmaceutica Sinica. B · 2014
Latest funding
- $592,876
Improving therapeutic outcomes in medulloblastoma through optimizing brain delivery of agents targeting inhibitors of apoptosis proteins
CIHR · 2024 · Nominated PI
- $145,222
Nanoparticle Tracking Analysis Platform for in vitro Characterization of Engineered and Natural Nanoparticles in Biological Fluids
NSERC · 2021 · Co-investigator
- $95,202
Coupling cellular dynamics with animal behaviour in small teleost models
NSERC · 2020 · Co-investigator
3 publications.
Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma
Martell E, Kuzmychova H, Senthil H, Chawla U, Kaul E, Grewal A, Banerji V, Anderson CM, Venugopal C, Miller D
Pharmacokinetics of a once-daily tacrolimus formulation in first nations and caucasian liver transplant recipients.
Peretz D, On NH, Miller D, Kim R, Franklin C, Dascal R, Knowles C, Minuk GY
Evaluation of percutaneous permeation of repellent DEET and sunscreen oxybenzone from emulsion-based formulations in artificial membrane and human skin.
Wang T, Miller D, Burczynski F, Gu X
Improving therapeutic outcomes in medulloblastoma through optimizing brain delivery of agents targeting inhibitors of apoptosis proteins
Principal investigators: Miller, Donald W
Keywords: Blood-Brain Barrier; Cadherin Binding Peptides; Chemotherapy; Drug Delivery; Inhibitors Of Apoptosis Proteins; Medulloblastoma; Optical Imaging; Permeability Modulators; Radiation Therapy
Nanoparticle Tracking Analysis Platform for in vitro Characterization of Engineered and Natural Nanoparticles in Biological Fluids
Principal investigators: Labouta, Hagar
Coupling cellular dynamics with animal behaviour in small teleost models
Principal investigators: Lindsey, Benjamin
Development and clinical assessment of novel biomarker drugs targeting SSAT1 for detection and therapeutic monitoring of glioblastoma
Principal investigators: Miller, Donald
Development and clinical assessment of novel biomarker drugs targeting SSAT1 for detection and therapeutic monitoring of glioblastoma
Principal investigators: Miller, Donald W; Maula Bux, Rashid A; Klonisch, Thomas; Lakowski, Ted M
Keywords: Biomarker; Blood-Brain Barrier; Drug Acetylation; Early Detection; Glioblastoma; Metabolomics; Spermine Spermidine Acetyl Transferase 1; Therapeutic Monitoring
Nanoparticle Based Cell Selective Modulation of SSAT1 Expression
Principal investigators: Miller, Donald
Cellular Mechanisms Regulating Blood-Brain Barrier Permeability
Principal investigators: Miller, Donald
Development of magnetic tumor killing nanoparticles to breakthrough the blood-brain barrier
Principal investigators: Miller, Donald W; Klonisch, Thomas; van Lierop, Johan
Keywords: Blood-Brain Barrier; Brain Endothelial Cell; Brain Tumor; Chemotherapeutics; Drug Delivery; Glioblastoma; Hyperthermia; Magnetism; Nanoparticles; Neuroinflammation
Development of magnetic nanoparticles to breakthrough the blood-brain barrier
Principal investigators: Miller, Donald
Phospholipid Receptors as Targets for Enhancing Drug Permeability to the Brain
Principal investigators: Miller, Donald W
Keywords: Blood-Brain Barrier; Brain Tumors; Drug Delivery; Endothelial Permeability; In Vivo Imaging; Lysophosphatidic Acid; Receptor Expression; Sphingosine 1-Phosphate
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Pharmacology and Therapeutics
- Medicine
- Surgery
- Laboratory Medicine and Pathology
- Immunology
Co-authors at University of Manitoba, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.